Details for New Drug Application (NDA): 017588
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
NDA 017588 describes GLEOSTINE, which is a drug marketed by Corden Pharma and is included in one NDA. Additional details are available on the GLEOSTINE profile page.
The generic ingredient in GLEOSTINE is lomustine. There are two drug master file entries for this compound. Additional details are available on the lomustine profile page.
The generic ingredient in GLEOSTINE is lomustine. There are two drug master file entries for this compound. Additional details are available on the lomustine profile page.
Summary for 017588
| Tradename: | GLEOSTINE |
| Applicant: | Corden Pharma |
| Ingredient: | lomustine |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 017588
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 10MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 40MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
